side-area-logo
Latest News

About Anteo

Anteo Diagnostics (ASX: ADO) is a global medical technology company, developing and commercialising products for sale into the lifesciences, in-vitro diagnostics, point of care, medical devices and bioseparations markets.

The Anteo group owns a patented nanoglue technology, which is used by healthcare customers as an addition to their existing tests, to consistently enable laboratory test results that can either be delivered faster, cheaper or with greater specificity.

Read more
FROM THE BLOG
Funding For New Rapid Blood Test To Help Detect Heart Attacks: Atomo Partners with Anteo

Anteo is pleased to announce that it will partner with Sydney-based Atomo Diagnostics to develop a clinical prototype of a cost effective and accurate point of care test for the

Continue
Anteo Diagnostics to Hit Huge Markets with New Partnerships

The latest Anteo Diagnostics news from Proactive Investors Australia: After a string of operational and financial milestones, Anteo Diagnostics (ASX:ADO) is set to integrate an expanding international medical technology business into

Continue
Video: Mix&Go™ Could Solve Clinical Sample Interference

The lecture our VP of Scientific Affairs, Josh Soldo gave at AACC 2015 is now available. Lecture summary Interference is a substance present in a patient specimen that can alter

Continue
SOME OF THE PEOPLE WE WORK WITH

Our strong partnerships hold the key to improved patient care.

IMRA-logo-GREY
cook_logo GREY
Scienion_Logo_GREY
Qiagen_Logo GREY
Veritas GREY
affymetrix_logo GREY